L. Dunn

Efficacy and safety of formoterol fumarate delivered by nebulization to COPD patients.

N. Gross, H. Nelson, K. Denis-Mize, 2008, Respiratory medicine.

Novel Combination Of Glycopyrrolate And Formoterol MDI (GFF-MDI) Provides Superior Bronchodilation Compared To Its Components Administered Alone, Tiotropium DPI, And Formoterol DPI In A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study In Patients With COPD

E. Kerwin, C. Fogarty, D. Quinn, 2011, ATS 2011.

Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD

R. Buhl, B. Kramer, C. Disdier, 2010, European Respiratory Journal.

Phrenic nerve function and its relationship to atelectasis after coronary artery bypass surgery.

P. Paré, N. Müller, R. Pardy, 1988, Chest.

Respiratory muscle performance in normal elderly subjects and patients with COPD.

R. Pardy, N. J. Morrison, L. Dunn, 1989, Chest.

Routine nebulized ipratropium and albuterol together are better than either alone in COPD. The COMBIVENT Inhalation Solution Study Group.

A. Buist, D. Auerbach, N. Gross, 1997, Chest.

Pharmacokinetics of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler formulated using co-suspension delivery technology after single and chronic dosing in patients with COPD.

P. Dorinsky, E. Kerwin, M. Gillen, 2019, Pulmonary pharmacology & therapeutics.

COPD patient satisfaction with ipratropium bromide/albuterol delivered via Respimat: a randomized, controlled study

M. Ghafouri, G. Ferguson, L. Dunn, 2013, International journal of chronic obstructive pulmonary disease.

Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD

B. Kramer, C. Disdier, C. Lassen, 2011, European Respiratory Journal.